BioLife Solutions, Inc. (BLFS) shares are up more than 20% to $2.30 in mid-day trading. The move comes on a big volume too with the issue currently trading more than 2.2 million shares, which dwarfs the average volume of 31K a day. Not seeing any news or rumors to account for the move.
BioLife Solutions, Inc. is a Bothell, Washington-based manufacturer of patented hypothermic storage and cryopreservation solutions for cells and tissues in the United States. Its stock has a high consensus analyst price target of $4.50, and a 52-week trading range of $1.50 to $4.05.
The T-12 profit margin at BioLife Solutions, Inc. is (51.98%). BLFS‘ revenue for the same period is $6.19 million.
In terms of share statistics, BioLife Solutions has a total of 12.11 million shares outstanding with 48.26% held by insiders and 0.90% held by institutions. The stock’s short interest currently stands at 0.09%, bringing the total number of shares sold short to 5,353.
BioLife Solutions has market cap of $27.84 million. The name is down 39.76% year-over-year ; up 39% year-to-date.